한국어
English
日本語
中文(简体)
Raloxifene Tablets (Raloxifene Hydrochloride Hemihydrate)
62.12mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Raloxifene hydrochloride monohydrate is a selective estrogen receptor modulator used for the prevention and treatment of osteoporosis.
MFDS ingredient code M259890
Raloxifene hydrochloride monohydrate belongs to the category of selective estrogen receptor modulators (SERMs). It is primarily used for the prevention and treatment of osteoporosis in postmenopausal women. It exhibits estrogen-like effects on bones while having different effects in other tissues.
This ingredient binds to estrogen receptors in the bones, inhibiting bone loss and maintaining bone density. At the same time, it blocks estrogen stimulation in breast and uterine tissues, reducing the risk of side effects. This is how it is effective in the prevention and treatment of osteoporosis.
Approved uses differ by product. Check each product's information for its actual use.
Unlike traditional estrogen preparations, raloxifene acts similarly to estrogen only in specific tissues, thereby reducing side effects. Compared to other SERMs, it can also be expected to have a preventive effect against breast cancer. This characteristic differentiates it as a selective drug specialized for the treatment of osteoporosis.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.